La filiale santé du groupe nucléaire, très engagée dans le développement des alphathérapies ciblées en oncologie, investit ...

Après plus d’un demi-siècle dans le giron de Sanofi, sa maison mère, le médicament le plus vendu de France passera bientôt sous la houlette du fonds d’investissement américain CD & R.

Sanofi (NASDAQ:SNY) shares gained on Friday after the French pharma giant exceeded analysts' estimates with its Q3 thanks mainly to earlier-than-anticipated vaccine sales and a 22% YoY rise in ...

A mesure que Sanofi s’approchait du terme de son processus définitif de sélection, les appels à bloquer la vente se sont montrés ... Biogaran par sa maison mère Servier.

Sanofi SAN-0.92%decrease; red down pointing triangle is in discussions with the French government to address concerns officials raised about a potential sale of a controlling stake in the company ...

PARIS, Oct 21 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab said on Monday it had entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella to U ...

(Reuters) - French drug maker Sanofi on Friday posted stronger earnings growth than analysts had expected in the third quarter, boosted by an earlier-than-anticipated start of the vaccination season.

Sanofi’s shares traded 0.2% lower on Monday morning in Paris. The stock has risen about 2% over the past 12 months. Despite the commitments it faces in France, CD&R has been drawn to the Sanofi ...

PARIS (Reuters) -Sanofi on Sunday reached an agreement on terms to sell a controlling stake in its consumer health unit Opella to U.S. private equity firm Clayton Dubilier & Rice (CD&R), French ...

Sanofi pitched today’s announcement in the context of its move last month to pay Orano Med and its partner RadioMedix 100 million euros upfront and commit up to 220 million euros in sales ...

"Sanofi trahit ses salariés": le groupe vend le Doliprane ... propriétaires au forum de l'éco-rénovation Yoanna Mansvelt, ...